Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30% ...
TIME and Statista have named 500 companies doing best for the Earth Methodology: How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback